Press Release

Acute Respiratory Distress Syndrome Treatment Market 2019 Global Analysis, Opportunities and Forecast To 2026

Global Acute Respiratory Distress Syndrome Treatment Market to Expand with Increasing Public and Private Sector Investments in Healthcare

Advancements in stem cell research is a major driving factor for the global acute respiratory distress syndrome treatment market growth. According to the National Centre for Biotechnology Information (NCBI), 75% of the acute respiratory distress syndrome treatment (ARDS) cases are classified as severe and 8% of the mild cases progress to becoming moderate or severe. The overall mortality rate of ARDS is found to be at a shocking 43%.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/acute-respiratory-distress-syndrome-treatment-market-101180

North America to Register High Growth; Asia-Pacific and Europe to Follow Suit

Among regions, North America is expected to grasp a major portion in the global acute respiratory distress syndrome treatment market share till 2026. The main reasons being development of new management guidelines for ARDS and advancements in alternative therapies. Asia-Pacific along with Europe is witnessing a steady rise in the number of ICUs and growing prevalence of ARDS. Latin America, Africa, and the Middle East are seen as promising regions with great business opportunities.

Regulatory Approvals Build Confidence Among Market Players

The global acute respiratory distress syndrome treatment market stands to benefit from the fast-paced clearances from government authorities. For example, Athersys received a fast-track approval from the FDA for its MultiStem program to treat ARDS. Many companies are also carrying out advanced research and developing innovative products. For instance, Altor BioScience is conducting research on ALT-836, an antibody-based tissue factor antagonist, for treating ARDS caused by infections. These developments are anticipated to elevate the global acute respiratory distress syndrome treatment market potential.

Fortune Business Insights identifies the following players in the market:

  • Pfizer, Inc.
  • Athersys Inc.
  • Faron Pharmaceuticals, Ltd.
  • GlaxoSmithKline plc.
  • Teva Pharmaceuticals USA Inc.
  • HEALIOS K.K.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/acute-respiratory-distress-syndrome-treatment-market-101180

Key questions answered in the Acute Respiratory Distress Syndrome Treatment Market report:

What will the market growth rate of Acute Respiratory Distress Syndrome Treatment market in 2025?

What are the key factors driving the Global Acute Respiratory Distress Syndrome Treatment market?

What are sales, revenue, and price analysis of top manufacturers of Acute Respiratory Distress Syndrome Treatment market?

Who are the distributors, traders and dealers of Acute Respiratory Distress Syndrome Treatment market?

Who are the key vendors in Acute Respiratory Distress Syndrome Treatment market space?

What are the Acute Respiratory Distress Syndrome Treatment market opportunities and threats faced by the vendors in the Asia Acute Respiratory Distress Syndrome Treatment market?

What are sales, revenue, and price analysis by types, application and regions of Acute Respiratory Distress Syndrome Treatment market?

What are the market opportunities, market risk and market overview of the Acute Respiratory Distress Syndrome Treatment market?

More Trending Topics From Fortune Business [email protected]

What is behind the Rise of the Point of Care Diagnostics Market?

The HIV Drugs Market should see a stand-out year in 2020 | Fortune Business Insights™

The Antipsychotic Drugs Market should see a stand-out year in 2020 | Fortune Business Insights™

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close